Nanovibronix Stock Buy Hold or Sell Recommendation
| NAOV Stock | USD 2.21 0.43 16.29% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding NanoVibronix is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell NanoVibronix given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for NanoVibronix, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out NanoVibronix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide. Note, we conduct extensive research on individual companies such as NanoVibronix and provide practical buy, sell, or hold advice based on investors' constraints. NanoVibronix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
NanoVibronix |
Execute NanoVibronix Buy or Sell Advice
The NanoVibronix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on NanoVibronix. Macroaxis does not own or have any residual interests in NanoVibronix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute NanoVibronix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
NanoVibronix Trading Alerts and Improvement Suggestions
| NanoVibronix generated a negative expected return over the last 90 days | |
| NanoVibronix has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 2.28 M. Net Loss for the year was (3.71 M) with profit before overhead, payroll, taxes, and interest of 1.96 M. | |
| NanoVibronix currently holds about 3.94 M in cash with (3.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
| NanoVibronix has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Successful Independent Study of the NanoVibronix UroShield Device Published in the Australian and New Zealand Continence Journal |
NanoVibronix current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. NanoVibronix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. NanoVibronix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
NanoVibronix Returns Distribution Density
The distribution of NanoVibronix's historical returns is an attempt to chart the uncertainty of NanoVibronix's future price movements. The chart of the probability distribution of NanoVibronix daily returns describes the distribution of returns around its average expected value. We use NanoVibronix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of NanoVibronix returns is essential to provide solid investment advice for NanoVibronix.
| Mean Return | -1.47 | Value At Risk | -16.06 | Potential Upside | 14.26 | Standard Deviation | 10.52 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of NanoVibronix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
NanoVibronix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as NanoVibronix, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading NanoVibronix back and forth among themselves.
| Shares | Armistice Capital, Llc | 2024-12-31 | 189.3 K | Citadel Advisors Llc | 2024-12-31 | 43.6 K | Ubs Group Ag | 2024-12-31 | 41.2 K | Vanguard Group Inc | 2024-12-31 | 30.2 K | Geode Capital Management, Llc | 2024-12-31 | 22.5 K | Virtu Financial Llc | 2024-12-31 | 19.4 K | Two Sigma Securities, Llc | 2024-12-31 | 11 K | Tower Research Capital Llc | 2024-12-31 | 6 K | Bank Of America Corp | 2024-12-31 | 32.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 |
NanoVibronix Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (26K) | (30K) | (2M) | (557K) | (501.3K) | (476.2K) | |
| Change In Cash | 6.2M | 204K | (5.0M) | 570K | 513K | 538.7K | |
| Free Cash Flow | (3.4M) | (4.4M) | (7.0M) | (3.6M) | (3.2M) | (3.4M) | |
| Depreciation | 6K | 4K | 2K | 1K | 900.0 | 855.0 | |
| Other Non Cash Items | 647K | 1.5M | 363K | 137K | 157.6K | 149.7K | |
| Net Income | (4.3M) | (14.3M) | (5.4M) | (3.7M) | (3.3M) | (3.5M) | |
| End Period Cash Flow | 7.5M | 7.7M | 2.7M | 3.3M | 3.8M | 2.6M | |
| Change To Netincome | 2.0M | (14K) | 10.4M | 717K | 824.6K | 783.3K |
NanoVibronix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NanoVibronix or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NanoVibronix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NanoVibronix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.48 | |
β | Beta against Dow Jones | -0.05 | |
σ | Overall volatility | 10.75 | |
Ir | Information ratio | -0.13 |
NanoVibronix Volatility Alert
NanoVibronix is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NanoVibronix's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NanoVibronix's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.NanoVibronix Fundamentals Vs Peers
Comparing NanoVibronix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NanoVibronix's direct or indirect competition across all of the common fundamentals between NanoVibronix and the related equities. This way, we can detect undervalued stocks with similar characteristics as NanoVibronix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of NanoVibronix's fundamental indicators could also be used in its relative valuation, which is a method of valuing NanoVibronix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare NanoVibronix to competition |
| Fundamentals | NanoVibronix | Peer Average |
| Return On Equity | -0.94 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Profit Margin | (0.94) % | (1.27) % |
| Operating Margin | (2.58) % | (5.51) % |
| Current Valuation | 568.94 K | 16.62 B |
| Shares Outstanding | 792.39 K | 571.82 M |
| Shares Owned By Insiders | 0.95 % | 10.09 % |
| Shares Owned By Institutions | 1.99 % | 39.21 % |
| Number Of Shares Shorted | 95.67 K | 4.71 M |
| Price To Earning | (5.34) X | 28.72 X |
| Price To Book | 0.93 X | 9.51 X |
| Price To Sales | 0.53 X | 11.42 X |
| Revenue | 2.28 M | 9.43 B |
| Gross Profit | 1.96 M | 27.38 B |
| EBITDA | (3.44 M) | 3.9 B |
| Net Income | (3.71 M) | 570.98 M |
| Cash And Equivalents | 3.94 M | 2.7 B |
| Cash Per Share | 0.14 X | 5.01 X |
| Total Debt | 5 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 3.07 X | 2.16 X |
| Book Value Per Share | 7.40 X | 1.93 K |
| Cash Flow From Operations | (3.6 M) | 971.22 M |
| Short Ratio | 0.05 X | 4.00 X |
| Earnings Per Share | (13.53) X | 3.12 X |
| Target Price | 10.5 | |
| Number Of Employees | 10 | 18.84 K |
| Beta | 1.81 | -0.15 |
| Market Capitalization | 1.75 M | 19.03 B |
| Total Asset | 6.67 M | 29.47 B |
| Retained Earnings | (66.1 M) | 9.33 B |
| Working Capital | 4.03 M | 1.48 B |
| Current Asset | 1.78 M | 9.34 B |
Note: Disposition of 563 shares by Brown Stephen Russell of NanoVibronix at 8.84 subject to Rule 16b-3 [view details]
NanoVibronix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as NanoVibronix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About NanoVibronix Buy or Sell Advice
When is the right time to buy or sell NanoVibronix? Buying financial instruments such as NanoVibronix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having NanoVibronix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Makers Thematic Idea Now
Chemicals Makers
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.